Fennec Pharmaceuticals (FENC) Profit After Tax Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.51% |
| Sep 30, 2025 | 35.77% |
| Jun 30, 2025 | 8.17% |
| Mar 31, 2025 | 21.06% |
| Dec 31, 2024 | 11.15% |
| Sep 30, 2024 | -26.18% |
| Jun 30, 2024 | -3.38% |
| Mar 31, 2024 | 47.10% |
| Dec 31, 2023 | 2.11% |
| Sep 30, 2023 | 7.45% |
| Jun 30, 2023 | -16.04% |
| Mar 31, 2023 | -31.01% |
| Dec 31, 2022 | -24.05% |
| Sep 30, 2022 | -27.72% |
| Jun 30, 2022 | -25.91% |
| Mar 31, 2022 | -34.86% |
| Dec 31, 2021 | -30.07% |
| Sep 30, 2021 | -53.04% |
| Jun 30, 2021 | -40.17% |
| Mar 31, 2021 | -63.52% |
| Dec 31, 2020 | -43.91% |
| Sep 30, 2020 | -116.40% |
| Jun 30, 2020 | -94.60% |
| Mar 31, 2020 | -87.97% |
| Dec 31, 2019 | -35.59% |
| Sep 30, 2019 | -46.37% |
| Jun 30, 2019 | -44.37% |
| Mar 31, 2019 | 3.84% |
| Dec 31, 2018 | -36.19% |
| Sep 30, 2018 | -9.25% |
| Jun 30, 2018 | -19.05% |
| Mar 31, 2018 | 17.52% |
| Dec 31, 2017 | 18.86% |
| Sep 30, 2017 | -25.22% |
| Jun 30, 2017 | -21.56% |
| Mar 31, 2017 | -18.09% |
| Dec 31, 2016 | -18.39% |
| Sep 30, 2016 | 30.71% |
| Jun 30, 2016 | -15.78% |
| Mar 31, 2016 | -15.89% |
| Dec 31, 2015 | 39.36% |
| Sep 30, 2015 | -15.69% |
| Jun 30, 2015 | 41.70% |